John Hormuth Email & Phone Number

Sammamish, Washington, Us

Entrepreneurial Specialty, Rare and Orphan therapy biopharmaceutical consulting firm focused on pre and post launch planning, tactics, implementation and ongoing oversight; Channel and HUB partner selection, implementation and ongoing partner, program and process management, developing and executing strategies and programs across all areas of Market Access (Channel, Patient, Payer and Provider) that bridges barriers faced by Patients in their journey to access buy and bill, assignment of benefit or pharmacy benefit reimbursed specialty products; Trade / Channel, Patient (HUB, Reimbursement and Affordability), Payer and Field Reimbursement strategies, tactics and ongoing management. Services include: Patient Access (HUB) and Affordability (co-pay, PAP and Bridge) program design, partner selection, program implementation, and ongoing management; Channel program design, partner selection, program implementation and ongoing management, Payer research and analytics, 3PL selection, GTN / ASP analysis, strategy and tactics, 340B analytics, contract and chargeback audits, asset valuations and Patient Advocacy engagement.

Pittsburgh, Pa, Us

Vice President, Client Development & ConsultingIntegral part of the executive leadership team. Focused on developing and driving value across the organization for it growing list of clients seeking Hub, Affordability and Reimbursement Services for Specialty Biopharmaceutical products. Provided operational and executive leadership, market insights into technology assessments and actively participated in positioning the organization to interested acquirers. • Developed and implemented a network of Specialty Distributors & Specialty Pharmacies partners that drove a 22% reduction in the time to therapy while providing enhanced services an ensuring alignment with payer reimbursement requirements. • Integral leadership in developing leading edge technology platforms that reduced speed to therapy by over 10% while reducing reimbursement investigation burden to HCP.• Designed and launch a Channel integration solution that drove HCP usage of HUB and technology solution to over 85%. • Developed and implemented solutions across several clients to ensure Patient affordability and temporary Payer barriers were reduced / eliminated so patient could quickly start therapy.

Conshohocken, Pa, Us

Focused on assisting clients in the design, development and implementation of multiple patient and provider service programs: HUBs, Reimbursement Support, Co-pay, Patient Assistance Programs, Nurse Support, REMS management and compliance. Breadth of pharmaceutical / biotechnology experience coupled with communication and leadership are critical factors to success in this position.

Seattle, Wa, Us

• Led 5 projects with a leading national Commercial, Managed Medicaid and Medicare Advantage Payer to understand and model the implications of Specialty product formulary selection / positions. Resulted in Payer increasing management, tier and other access barrier placement, of Specialty Product via Pharmacy Benefit.• Responsible and engaged biopharmaceutical clients with 4 primary research projects to understanding the actions Payers take to manage access to Specialty Products and how this landscape evolving at National, Regional, Local and Employer levels. Resulting in developing creative value proposition strategies to overcome the various barriers payers placed on product access.•Successfully expanded the client base of the practice to include multiple Biotechnology and Pharmaceutical companies.•Responsible for the delivery of several product/payer/managed care focused projects for Biotechnology and Pharmaceutical clients. These projects provided clients with a detailed analysis of the access to the product(s) in question as well as strategies to overcome access Barriers.

Successfully led and developed the company's commercial team that was responsible for launching over 20 products. Responsibilities included developing Brand Marketing, Market Access Strategy, Pricing and Contracting, securing J Code, Payer Patient and Provide insights, Development of Hub with a REMs Payer strategies and tactics for each launch and manage throughout the life cycle of the products. Leadership, communication, cross-functional collaboration, quick adaption to very fluid market conditions and broad base problem solving were critical attributes for achieving success in this position. • Responsible for GTN for commercial product profile and grew net revenue over 50%.• Developed and managed KOL relationships and conducted primary market research for the three branded generic products that were in the Immunology, Cardiology and Nephrology therapeutic classes. • Led the Commercialization Strategy team for the company's products across multiple channels (IDNs / Hospitals, LTC, GPO, Specialty Pharmacy, Specialty Distribution, Retail, MCO/PBM) and across the organization.• Initiated and led cross-functional team of Regulatory, Development, and Supply Operations to ensure strategic alignment across functional areas in order to optimize product(s) FDA position as well as the products value proposition.

Thousand Oaks, Ca, Us

Directed and developed trade/specialty marketing, sales, key business to business account management, contracting and distribution strategies for Amgen's US business unit: + $10B and $1B in Accounts Receivable in all channels of trade.• Led the development, analysis and negotiations of the business terms of the initial and subsequent Distribution Service Agreements as well channel partner programs. Reduced GTN impact of Channel fees by more than $10 Million. • Led specialty and nonspecialty trade/channel strategies and relationship efforts and worked collaboratively with Payer and Oncology GPO partners to ensure pull-through of product.• Initiated and led a several cross functional teams. Focus of team was on increasing market share as well as operational efficiency with business partners. This team delivered an ROI of greater than 50%, reduction of 2 FTE, improved the order to cash cycle by more than 14 days and collect more than $15M in doubtful accounts. • Earned a coveted first for Amgen, recognized by a Fortune 20 customer as the most Operational Efficient partner in the Biotechnology and Pharmaceutical industry.• Award winner - Leadership Excellence, President’s and Chairman Circle winner for all years of eligibility for proactively leading many teams as well as gaining behind the scenes support for many key strategies.

Responsible for the all aspects of operation and business transactions (Inventory, Returns, Contracts and Chargebacks, Accounts Receivable / Risk management) with direct Trading partners across all channels of distribution: Retail, Specialty Pharmacy, Specialty Distribution, HCPs Alternate Site, Wholesalers and Large HMO Payers. • Co-crafted and implemented the open Channel strategy for Enbrel’s launch and ongoing Channel strategy. Efforts focused on developing a robust cold chain drop ship channel model as well as ensuring that this method of distribution was equipped to accommodate a + $1B product. Ensuring open access to the product as well as maintaining a clean and traceable pedigree.• Developed and implemented the largest mandatory Patient and Provider registration program - more than 35,000 patients and over 5,000 providers. The focus of this program was to manage supply and demand of Enbrel for a period of over 3 – 4 years until an additional manufacturing capacity as available.• Led and accountable for the analysis and negotiations of the channel partners Distribution Service Agreements and other contracting services. • Directed cross functional team to manage over $50 million in Account Receivable risk associated with the rapidly deteriorating financial position of a key trading partner. Resulted in trading partner to maintain over $30M on account in order maintain an ongoing business relationship. • Emerald Award winner in all years of eligibility. The awards were earned as a result of the exceeding all sales goals and creating solutions to drive the nationwide sales of Immunex portfolio of products.August 2002 Immunex was acquired by Amgen.

Indianapolis, Indiana, Us

Mba, Finance

Bs, Business Management And Marketing

Executive Leadership Program - Marketing, Sales And Marketing Leadership